Angiogenesis patch trial moves forward:
This article was originally published in Clinica
Executive Summary
Advanced Tissue Sciences has begun a pivotal preclinical trial of its tissue-engineered epicardial patch for stimulating new blood vessel growth and improving the function of damaged heart tissue. The trial will assess the safety of the patch, called Anginera, in large animals. A previous study in mice has shown that the patch can improve overall function in damaged heart tissue without adversely effecting normal heart tissue function. Studies in large animals are required by the US FDA before starting human trials, noted the La Jolla, California firm. An efficacy trial in large animals is to begin this summer.